Information Provided By:
Fly News Breaks for March 12, 2015
EGLT
Mar 12, 2015 | 08:29 EDT
JMP Securities increased its price target on Egalet after the company announced clinical and regulatory updates for its Egalet-001 drug. The firm thinks the updates accelerate the time to approval and increase the probability of approval for the product.It reiterates an Outperform rating.
News For EGLT From the Last 2 Days
There are no results for your query EGLT
I agree to the thefly.com's disclaimer & terms of use
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.